Advanced search
Publication Cover
Journal of Dermatological Treatment Volume 33, 2022 - Issue 5
Submit an article Journal homepage
3,843
Views
1
CrossRef citations to date
0
Altmetric
Articles

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)

Marjolein de Bruin-Wellera National Expertise Center of Atopic Dermatitis, Department of Dermatology and Allergology, University Medical Center, Utrecht, The NetherlandsView further author information
,
Andrew E. Pinkb St. John’s Institute of Dermatology, Guy’s and St Thomas’ NHS Foundation Trust, London, UKView further author information
,
Silvia M. Ferruccic Department of Dermatology, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, ItalyView further author information
,
Annalisa Patrizid Department of Dermatology, IRCCS Policlinico di S. Orsola, Department of Experimental, Diagnostic, and Specialty Medicine, University of Bologna, Bologna, ItalyView further author information
,
Ake Svenssone Skåne University Hospital, Malmo, SwedenView further author information
,
Marie L. A. Schuttelaarf Dermatology, University Medical Center Groningen, University of Groningen, Groningen, NetherlandsView further author information
,
Marie Tauberg Dermatology and Allergology Department, Toulouse University Hospital, and Institute for Infectious and Inflammatory Diseases, INSERM UMR1291 – CNRS UMR5051, Toulouse, FranceView further author information
,
Marius Ardeleanuh Regeneron Pharmaceuticals, Inc, Tarrytown, NY, USAView further author information
,
Shyamalie Jayawardenai Sanofi, Bridgewater, NJ, USAView further author information
&
Moataz Daoudj Sanofi Genzyme, Cambridge, MA, USACorrespondence[email protected]
View further author information
 show all
Pages 2565-2570 | Received 16 Nov 2021, Accepted 22 Jan 2022, Published online: 08 Mar 2022

Related Research Data

Use of systemic therapies in adults with atopic dermatitis: 12-month results from the European prospective observational study in patients eligible for systemic therapy for atopic dermatitis (EUROSTAD)
Source: Taylor & Francis

Linking provided by 

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.